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ABSTRACT.
In an effort to combat the rising cost of health care in the United States by
encouraging preventative and self-care, the federal government passed the Dietary
Supplement Health Education Act of 1994. This act essentially deregulated the natural
product market allowing herbs, including yohimbine, to be sold over the counter without
undergoing the same strict evaluation as a traditional synthetic drug candidate. As the
full potential of these natural products is realized, including possible harmful side effects,
a need arises for the identification and quantitation of the active components from
commercial preparations.
Commercial samples were qualitatively and quantitatively analyzed for
yohimbine utilizing a capillary electrophoretic method optimized through statistical





10) and extraction efficiency (99.8% recovery) were
determined to be sufficient. It was shown that a statistical design could limit the amount




The West African tree Yohimbe is located in the low altitude, jungle forests
enveloping southwestern Nigeria. Growing from 20 to 50 feet high, this tall evergreen
forest tree has glabrous, leathery leaves three to five inches in length with upcurving
lateral nerves that fade out at the margins. White flowers, containing winged seeds, are
arranged in umbel-like clusters at the ends of the shoots (1, 2). It is the compounds found
in the bark of this tree that have historically drawn attention towards the Yohimbe.
Documentation of the Bantu-speaking people describes yohimbe as an
aphrodisiac and stimulant traditionally used during mating rituals that last up to 15 days.
There are several methods of preparing yohimbe bark for use (2). A tea is prepared by
boiling yohimbe bark shavings in water for less than four minutes. Heat is then turned
down, allowing the brew to simmer for an additional 20 minutes. The shavings are
strained, and the tea is sipped one hour before the desired effects are to be realized.
A method that leads to the effects in a shorter time after ingestion involves
extraction of the bark powder with a drinkable alcohol. After a period of eight hours, the
alcohol is strained and evaporated, leaving a residue that can be snuffed or taken
subcutaneously. Effects through this method are more pronounced, occurring within
twenty minutes (2).
The bark is reported to contain up to 6% yohimbine (Figure 1), along with a
number of similar indole alkaloids including yohimbenine, isoyohimbine




Figure 1. Molecular structure ofYohimbine.
the form of the hydrochloride is also known as quebrachine, isolated from the South
American evergreen Quebracho tree (2, 3) as well as from Rauwolfia viridis leaves (4),
Rauwolfia caffra root bark and seeds (5), Rauwolfia serpentina root (6), Rauwolfia
oreogiton root (7), Rauwolfia volkensii root (7), Rauwolfia vomitoria root (8), and
Rauwolfia yunnanensis (9).
Yohimbine is the most interesting alkaloid from these sources, having gained
notoriety in a number of circles as an alternative medicine treatment. Suggested for
human use in bodybuilding as an alternative to anabolic steroids (1, 10), yohimbine has
been employed in veterinary medicine as an antagonist for anesthesia and sedation of
animals, as well as for the treatment of impotent stallions (11, 12). Classified as an
alpha-2-adrenergic blocker, this sympathomimetic indole-type alkaloid also displays
serotonin inhibiting properties (1,2). In both humans and animals, yohimbine produces a
complex pattern of responses that include anti-diuresis and central excitation, comprising
elevation of blood pressure and heart rate, increased motor activity and irritability (13).
Recent focus has been concerned with the aphrodisiac properties and use of yohimbine as
a treatment for human erectile dysfunction (14-35).
The marketing of yohimbine falls under the Dietary Supplemental Health
Education Act (DSHEA) of 1994, a governmental effort to limit the skyrocketing cost of
United States health care that has essentially deregulated the natural product market.
Natural products are not strictly evaluated pre-market as a synthesized drug candidate
would be, and tend to draw scrutiny only when adverse effects are noted as a result of
consumer use. Regulatory action toward another natural product with central nervous
system stimulant properties, ephedrine, arose only after toxic levels were witnessed
clinically (36, 37). These complications may be due to the inherent properties of the
sources from which these natural products are harvested, namely vegetation. Alkaloid
quantities from two distinct plants may be different from different regions, quantities may
be different between two distinct plants in the same region, or quantities may be different
between two leaves on the same tree. A preparation of natural products may in turn have
varying concentrations between batches, between bottles, and even between pills in the
same bottle for this reason. This is an important consideration for a compound that has a
small range between a therapeutic dose and toxic dose, when product variance could
mean the difference between life and death.
As the drawbacks of the DSHEA are eventually realized and attention focuses on
dose reproducibility, qualitative and quantitative characterization of many natural
products, including yohimbine, will gain importance. Efforts have thus far been reported
toward the identification and quantification of yohimbine in commercial products and
biological fluids utilizing fluorescence (6), ultra-violet spectroscopy (UV) (5-8), infrared
spectroscopy (IR) (7, 8), nuclear magnetic resonance spectroscopy (NMR) (8), thin-layer
chromatography (TLC) (6, 38, 39), gas chromatography (GC) (10), gas chromatography/
mass spectroscopy (GC/MS) (8, 13), gas-liquid chromatography (GLC) (5), liquid
chromatography (LC) (40), and high-performance liquid chromatography (HPLC) (6, 13,
39-44). There have been no reported investigations of yohimbine utilizing capillary
electrophoresis, a technique that is swiftly gaining prominence in the analytical
laboratory.
History ofCapillary Electrophoresis.
In the 1930's Arne Tiselius developed the first moving boundary electrophoresis
method utilizing an open U-shaped quartz column. Protein mixtures in free solution were
partially resolved as abutting bands detected by ultraviolet absorbance (45). However,
this pioneering technique had drawbacks that included large sample volumes, and an
incomplete separation of the proteins.
Investigation of improved anticonvective media in subsequent decades directed
the focus toward zone electrophoresis. Polyacrylamide gels, developed in the late
1960's, contain stacking and resolving buffer systems that yield native protein and
sodium dodecyl sulfate (SDS) bound protein separations (46). Known as polyacrylamide
gel electrophoresis (PAGE) and SDS-PAGE, these techniques continue to give high-
resolution separations as important tools in biochemical characterization.
Around the time PAGE was designed to separate proteins on the basis of charge
or size, an investigation was underway to develop a separation based on protein
isoelectric points. Isoelectric focusing (IEF) employs a gel containing an immobilized
pH gradient constituted of a mixture of ampholytes. Vesterberg is credited with
deprotonated (50). Hydrated buffer cations coordinate to the anions at the capillary wall
to form the rigid Helmholtz layer, and the mobile Gouey-Chapman layer to complete
electroneutrality (Figure 3). A drop in negative potential, described by the zeta potential,
characterizes the Gouey-Chapman layer: the magnitude of wall negative charge is
directly proportional to layer thickness. While this region extends only a few nanometers
beyond the Helmholtz layer, it is the mobile cations contained within that generate bulk




Figure 3. Interactions at the capillary wall that fuel electroosmotic
flow. Not shown: hydrated anions in the diffuse layer
(Outer-Helmholtz region).
resulting in a net flow toward the cathode under an applied voltage. Immediately upon
the application of voltage, cations in this layer will have a greater velocity then the
remainder of the capillary cross section. The resultant flow profile may have a parabolic
character as the electrophoretic mobility of cations in the diffuse portion of the capillary
are partially shielded by coordinated mobile anions with an opposite pe. This
phenomenon would appear similar to a laminar flow profile towards the anode, but in fact
EOF is in the direction of the cathode (Figure 4). Once a steady state is reached, a 'plug-
}
Figure 4. Reverse laminar flow diagram
like'
flow is obtained at any cross sectional area beyond the Helmholtz plane, as this
pulling force is uniform for the length of the capillary. Cation flow near the capillary wall
inside the rigid Helmholtz layer approaches zero, resulting in the accepted depiction of









The term capillary electrophoresis describes the family of separation techniques
based on the mobility differences of charged species under an applied voltage. Mention
should be given to the variations on this empirical analytical technique that have gained
10
popularity toward specialized analysis. A summary of the notable techniques and
applications follows.
Capillary Zone Electrophoresis (CZE).
Capillary zone electrophoresis is the electrophoretic separation of ions in a buffer
solution under an applied voltage.
Micellar Kinetic Capillary Chromatography (MEKC).
Upon the addition of anionic surfactant molecules above a critical micelle
concentration (CMC), hydrophobic tails of these molecules coordinate, exposing their
hydrophilic heads and assuming a spherical shape characteristic of a micelle. These
micelles have a ue toward the anode. Analytes in this electrophoretic system are further
resolved on the basis of hydrophobicity as interaction with the micelles delays the
observed migration.
Capillary Gel Electrophoresis (CGE).
The capillary is loaded with a gel, such as polyacrylamide, commonly employed
in PAGE. Analytes are then separated based on charge to size ratio under an applied
voltage. This technique has a high resolving power for proteins, peptides, and amino
acids.
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Capillary Isoelectric Focusing (CIEF).
An electrolyte containing a mixture of ampholytes and sample is loaded onto the
column. When voltage is applied, the ampholytes migrate to form a continuous pH
gradient in the capillary. Analytes migrate to the location on capillary that corresponds to
their pi. The voltage is removed, and capillary contents are eluted past the detector under
an applied pressure.
Capillary Isotachophoresis (CITP).
This is a moving boundary electrophoretic technique. The sample plug is
introduced after a leading electrolyte with mobility faster than the fastest analyte, and
before a terminating electrolyte of slower mobility than the slowest analyte. Compounds
are resolved within the sample plug as itmigrates toward the detection window.
Capillary Electrochromatography (CEC).
CEC is a capillary electrophoretic technique utilizing a capillary packed with one
of any number of stationary phases used in HPLC. This technique can employ pressure,
voltage, or a combination of the two as the driving separation force. This is useful in the
separation of charged analytes that differ in hydrophobicity. The investigation of this




Recently, statistical experimental designs have been increasingly employed as a
useful option in analytical method development. A factorial design is equipped to
address several major experimental concerns for which the traditional One Factor at a
Time (OFAAT) trial and error development technique is not suited (52).
Joint effects or interactions are the effect that the simultaneous variation of two or
more experimental parameters will have on response. These effects can only be
identified and studied by the correlative change of the selected factors. The OFAAT
method involves systematically optimizing one experimental variable, while holding all
other variables constant. The method is then optimized for a second variable, again
keeping all other variables constant. Subsequent variables are investigated in the same
manner. To evaluate joint effects with this design, it is necessary to reevaluate variable
one upon optimization ofvariable two, then the reevaluation of variable two with changes
in variable one, eventually moving through all variables in this systematic approach.
Clearly, the number of experimental runs would quickly become exhausting as the
number of investigated variables increased.
A factorial experimental design allows for the systematic investigation of joint
effects by enabling a statistical analysis to interpret the significance of factor levels, while
limiting the number of experimental runs needed. This design is useful when expense,
quantity ofmaterial or time are limited, as experiment numbers are significantly reduced.
There are several software programs that are capable of handling the complex
calculations to analyze data from a factorial design, but it is useful to understand how
these values are computed to employ this technique.
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development of the method for synthesizing ampholyte mixtures for high-resolution IEF
in 1969, still a separation technique found in the modern biochemistry laboratory (47).
O'Farrell combined IEF with SDS-PAGE in the 1970's, creating two-dimensional
electrophoresis, a technique capable of resolving more than 50 components in each
direction. Utilizing an isoelectric point separation followed by an electrophoretic
separation in the perpendicular direction, several thousand compounds can be isolated
with this approach (48).
During the late 1970's, the family of gel electrophoretic techniques gained
acceptance in biochemistry laboratories, opening doors for investigation of protein-based
biopharmaceuticals. Meanwhile, high performance liquid chromatography (HPLC) was
gaining notoriety as an analytical tool in pharmaceutical and chemical laboratories.
Along with high resolution, HPLC offered ease of automation, and excellent quantitative
precision for the determination of low molecular weight compounds and industrial
polymers (49). As gel techniques were applied in an industrial setting, their detection
limitations and inherent lengthy, involved preparation procedures did not compare
favorably to the swift and reliable chromatographic techniques employed at the time.
This prompted pharmaceutical and bioanalytical chemists in these fields to turn their
attention to HPLC for biomolecule characterization as protein, peptide, and nucleic acid
chromatographic media became available during the early 1980's, (50).
A strong environmental awareness movement occurred in the 1980's as the
biotechnology field broadened. This involved a chain of events effectively increasing
waste disposal costs. A main analytical tool at this time, HPLC, routinely generates large
amounts of organic solvent waste, which inferred a high cost of daily operation based on




design: variation of three factors (k =
3) at two levels. For example; the effect of temperature (factor A: 25, 37), pressure
(factor B: 1 atm, 3 atm), and wavelength (factor C: 300 nm, 500 nm) on photosynthesis
by a newly discovered algae. An experimental run chart is assembled and completed,
recording the response (Table 1). There are four sets of experimental runs where factor
Table 1 .
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Factorial experimental design. Three factors (A,B,C) at two levels: low (-) and high (+).
Run Number Factor A Factor B Factor C Response (X)
1 - - - X,
2 + - - x2
3 - + - x3
4 + + - x4
5 - - + x5
6 + - + x6
7 - + + x7
8 + + + x8
A is varied as factors B and C remained constant. Runs 1 and 2, where A changes while
B and C are both negative: Runs 3 and 4, where B is positive, and C is negative: Runs 5
and 6, where B is negative and C is positive: Runs 7 and 8, where B and C are both
positive. Therefore, the effect of factor A can be described through Equation 2.
Effect A = ((X2-XQ + (X4-X3) + (X6-X5) + (Xg-X?))
4
The number generated describes the effect ofmoving from a low to a high level in
A, regardless of the levels ofB and C. This calculation can be completed for each of the
factors employed in a factorial design to determine their effect (52).
14
Joint effects are handled in a similar manner. For this analysis, the design has two
pairs of data points with a variation ofA; one at the high level of B, the other at the low
level, while C remains constant. Half of the difference of these two pairs is the value of
the AB interaction (Equation 3).
Effect A at positive B = ((X - X7) + (Xfi - Xs))
2
Effect A at negative B = ((X* - X,) + (X, - X^)
2
Effect AB = ((Effect A at positive B) - (Effect A at negative B)) 3
2
Scheme 1.
This calculation can be completed for each factor of interest to determine the
magnitude of joint effects. Utilizing computer software in the handling of these
equations dramatically lowers analysis time for this as well as a larger model.
Due to the number of factors that affect a separation in Capillary Electrophoresis,
a factorial design presents an interesting choice for a thoroughly systematic method
development. Separation voltage, temperature, buffer type, buffer pH, buffer ionic
strength, column length, organic modifier concentration, injection type, and injection
setpoints are nine relevant factors. To investigate the main and interaction effects of




or 512 runs would be needed.
It is possible to lower this number, utilizing a fractional factorial design (55, 56).
15
Fractional Factorial Design.
There are several advantages to utilizing a fractional factorial design when the
numbers of experimental variables in a factorial investigation are large. There is little
loss of information while significantly lowering the length of experimentation (52, 53).
Consider the design of a
2s
factorial experiment (Table 2). This investigation would
Table 2. 2 Factorial design. (Five factors at two levels, centerpoints excluded).
Run Factor A Factor B Factor C Factor D Factor E Response (X)
1 - - - - ^
2 + - - - - x2
3 - + - - - x3
4 + + - - - X4
5 - - + - - x5
6 + - + - - Xe
7 - + + - - x7
8 + + + - - X8
9 - - - + - x9
10 + - - + - X10
11 - + - + - X11
12 + + - + - X12
13 - - + + - X13
14 + - + + - X14
15 - + + + - X15
16 + + + + - X16
17 - - - - + X17
18 + - - - + X-I8
19 - + - - + X19
20 + + - - + X20
21 - - + - + X21
22 + - + - + X22
23 - + + - + X23
24 + + + - + X24
25 - - - + + X25
26 + - - + + X26
27 - + - + + X27
28 + + - + + X28
29 - - + + + X29
30 + - + + + X30
31 - + + + + X31
32 + + + + + X32
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require the collection of 32 data points. Generating a fractional factorial design of a %
fraction of this table would require only 8 experimental runs (Scheme 2), with a
2(k-s) = 2(5-2) =
23
= 8
Where k - number of factors and s is derived from the equation
1/4 =
(l/2)s
Where the fraction =1/4.
Scheme 2. Generation of a % fractional factorial
design of five factors at two levels (k = 5, s
= 2).
minimum of information loss due to confounding. Any 3 (k-s) factors are set up in a full
factorial experiment. It is first necessary to determine design generators (53). Design
generators represent the products of multiplying together a combination of the + and
values from these first three columns. It is necessary to utilize s number of unique
generators for a fractional factorial design; these generators must not be the products of
any other generator combination (Scheme 3). The values for the fourth factor column are
produced
D = AC, E
= AB
AC * AB = AACB = CB
Scheme 3. Design generators for factors D and E. The implicit
design generator is CB, the unique product ofDE.
by multiplying the + or
- in columns A and C, corresponding to the design generator for
variable D and resulting in a + or . The values for the fifth factor column are then
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produced by multiplying the + or - in columns A and B, corresponding to design
generator E. The result is a V* fraction of a
25
factorial design (Table 3).
Table 3. Va fraction of a
2s
factorial design. Generators D = AC, E
= AB.
Run Factor A Factor B Factor C Factor D Factor E Response (X)
1 - - - + + Xi
2 + - - - - x2
3 - + - + - x3
4 + + - - + x4
5 - - + + - x5
6 + - + + - x6
7 - + + - + x7
8 + + + + + x8
There are three additional quarters that can be represented by the design generators D
= -
AC and E = -AB, D
= AC and E = -AB, or D
=
-AC and E = AB. The quarter chosen to
be utilized is arbitrary.
It is important to understand and account for confounding factors. If several
measurements are made when two factors are at the lower level, and also when the two
factors are at a high level, but not when the factors are at different levels, the effect due to
the individual factors can not be estimated. Any information lost in a fractional design
can be attributed to these confounding factors.
Resolution of a fractional factorial design is determined as the minimum number
of variables employed in the design generators, a number that relates to the confounding
of factor interactions. In the example above for a % fraction of a
25
design, the resolution
(R) is calculated as R
= 2. Effects having an order less than 2 are not confounded with
any other effect with order less than
t = R - e factors (53). In a design with a resolution




factor interaction (t = 2). Two-factor interactions (e = 2) are not confounded with main
effects but may be confounded with other two factor interactions (53).
When approaching a complex analytical technique such as capillary
electrophoresis, it may be beneficial to utilize a fractional factorial design toward method
development, ruling out a large number of influential factors with a limited amount of
experiments.
Summary.
At this time, there have been no reported studies concerning the usefulness of
capillary electrophoresis in the qualitative and quantitative analysis of yohimbine from
either commercially available products or biological fluids. This paper will deal with the
investigation of capillary electrophoresis as an analytical tool for the qualitative and
quantitative analysis of yohimbine in commercially available products. In addition, the
use of a factorial experimental design will be evaluated to investigate nine important
factors that influence capillary electrophoresis method development.
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DEFINITIONS IN CAPILLARY ELECTROPHORESIS.
Area.
The area under a peak on an output electropherogram.
Capillary Effective Length (I).
Length of the capillary employed from inlet to detector window.
Capillary Total Length (L).













This value is calculated by dividing the effective capillary length by the migration
time
Joule Heating.





Where: V = applied voltage
L = total capillary length
Migration Time.
Migration time is described as the amount of time for a compound to travel from
the point of injection to the point of detection in capillary electrophoresis. This value is
analogous to a retention time in liquid chromatography (LC). However, separations of
compounds in CE are a function of individual compound mobilities under an applied
voltage, where LC separations are a function of individual compound interactions with a
stationary phase.
Resolution (Rs).






Symmetry is ameasure ofpeak shape deviation from a Gaussian curve.
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Theoretical Plates (N).





D = Diffusion coefficient of the solute in the buffer system
E = Electric Field
I = Column effective length
Zeta Potential (Q.
The zeta potential is a measurement of the potential difference between
the capillary wall and the buffer solution within.
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this waste removal. Renewed interest surfaced at this time for the development ofmicro-
bore column chromatography in an effort to reduce solvent waste. The development of
this technique theoretically lowers experimental costs while maintaining resolution (50).
A combination of the positive aspects of these techniques are employed in capillary
electrophoresis, which utilizes a charge based separation in a microbore column.
Hjerten described the first capillary electrophoresis design in 1967 while at the
University of Uppsala in Sweden (51). Utilizing 1- to 3-mm internal diameter quartz
capillaries coated with methylcellulose, separations of inorganic ions, proteins, nucleic
acids, and microorganisms were demonstrated by free zone electrophoresis and later,
isoelectric focusing. Capillary technology appeared to be detrimental to the evolution of
this technique, as variations in optical pathway and large column diameters were the
limiting factors of performance (50). Gel techniques remained superior for these
applications due to the availability of the necessary technology at the time.
During the latter part of the 1980's, the investigation of capillary electrophoresis
advanced due to the useful advantages of small amount of solvent employed and the
qualitative precision obtained in analysis of biopharmaceuticals. This evolution was
aided by the technology found in gas chromatography, in the form of small internal
diameter fused silica capillaries, and from advances in HPLC, namely improved detector
and autosampler capabilities. CE has since emerged as a technique complimentary to
HPLC that offers reliable, efficient separations for several unique applications in the
biotechnology and biopharmaceutical fields. The separation of structural proteins (49,
50), restriction digests (49, 50), and PCR products (50) are only a few of the examples
that this expanding technique envelopes.
Theory ofCapillary Electrophoresis.
Capillary electrophoresis (CE) is the family of separation techniques based on the
mobility differences of charged species in free solution under an applied voltage.
Typically, a fused silica capillary with an internal diameter between 25 and 100 um is
placed between two buffer reservoirs. The capillary is filled with buffer, then a high
voltage is applied to the electrodes in each buffer reservoir, creating an electric field
across the length of the capillary (Figure 2). It is within this electric field that a
separation based on charge to size ratios is afforded. Detection of resolved analytes is
achieved on-column through a window on the capillary from which the external coating
has been removed.
v;
Figure 2. CE Schematic
ElectrophoreticMobility.
Electrophoretic mobility (pe) is described as the velocity that an ion demonstrates
under an applied voltage. Magnitude of mobility is a function of separation buffer pH
effect on analyte charge. Theoretically, anions have pe towards the anode, cations have
Pe toward the cathode, and neutral analytes will demonstrate no pe- However, in the
capillary electrophoretic separation of a mixture of cations, anions, and neutrals, at a
neutral or alkaline pH, peaks characteristic for each species will be seen on the resultant
electropherogram. This result infers that regardless of charge, each ion will have a net
mobility toward the cathode. The phenomenon that contributes to this peculiar effect is
called electroosmotic flow (EOF).
Generation ofElectroosmotic Flow.




Where: s = dielectric constant of the buffer
r|
=
viscosity of the buffer
, = zeta potential measured at the capillary wall
buffer solution under an applied voltage. This flow is directed toward the cathode in a
bare fused silica capillary when buffer pH is above three.
As buffer pH is increased between three and eight, the walls of the fused silica
capillary are proportionally deprotonated, inferring a negative charge on oxygen at the
capillary surface. Above a pH of eight,




Standard Company CAS# EEC#
Yohimbine hydrochloride Sigma 65-19-0 200-600-4





Buffer Component Company CAS#














Methanol J.T. Baker 67-56-1
Capillary Electrophoresis Reagents.
CE Reagent Company Part#
1.0 N Sodium Hydroxide
Solution for HPCE
Hewlett Packard 5062-8576
0.1 N Sodium Hydroxide
Solution for HPCE
Hewlett Packard 5062-8575




Hewlett Packard HP 3D-CE, Model # G1602A, Serial # 3546G00733
Computer:
Hewlett Packard Vectra XM series 3 5/90.
Control Program:
Hewlett Packard HP 3D-CE Chemstation. Revision A.05.04 [273]
Labline Environmental Orbital Shaker.
Rotary Evaporator:
Labconco Centrivap Concentrator. Catalog # 78 1 00-00
Labconco Cold Trap. Catalog # 781 10-00
Fisher Scientific Vacuum Pump. Maxima C Plus. Model M4C.
pH Meter:
VWR Scientific. Model 8005
Beckman Combination Electrode 39846. Lot 59098
Experimental Supplies.
Capillary:
Polymicro Technologies. 25pm Internal Diameter Fused Silica capillary,
360 pm Outer Diameter Polyimide coating. Part #: 200001 1
Syringes:
Becton Dickinson and Company: 10 cc syringe, 2.5 cc syringe
Filter discs:
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Acrodisc, sterile syringe filter. Pore size: 0.2pm, Diameter: 25mm. HT Tuffryn
membrane. Product #4142
Commercially Available Products:.
Action Labs, Farmingdale, NY.
Yohimbe Powermax 2000- 50 capsules
Pure Yohimbe Bark Extract. Maximum Potency. Fast Acting.
Yohimbine Bark Extract Complex: 2000 mg/ 2 Capsules
Yohimbe Powermax 2000- 2 fluid ounces
Pure Yohimbe Bark Extract. Maximum Potency. Fast Acting.
Extract ofYohimbe Bark: 2000 mg/ 2ml
General Nutrition Corporation, Pittsburgh, PA.
Men's Yohimbe 451- 60 Capsules
Standardized Herbal Support Preparation.
Yohimbe Bark Extract (Pausinystalia yohimba): 451 mg/ Capsule
(2% Yohimbine Alkaloid = 9 mg)
Great AmericanNutrition, Salt Lake City, UT
Men 's Performance- 20 Tablets
Herbal Formula. Intimacy Formula for Men. Maximum Potency.
Yohimbe (Pausinystalia yohimbe) (bark): 250 mg/ Tablet
IrwinNaturals, Culver City, CA.
Yohimbe-Plus- 30 Extra Large Tablets
Five High Potency Herbs forMale Drive and Stamina
2000 mg Daily Supply ofYohimbe. Guaranteed Potency.
Yohimbe Bark Powder: 2000 mg/ 3 Tablets
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Natrol, Chatsworth, CA.
Yohimbe Bark. Whole Herb Powder- 90 Capsules
Yohimbe, powdered (bark): 500 mg/ Capsule
OnlyNatural, Island Park, NY.
Yohimbe 1000plus- 10 tablet trail pack
ForMen Only Booster. 100% Pure African Yohimbe Bark.
Yohimbe Bark. (100% Pure African Bark): 1000 mg/ 2 Tablets
Power Force, Hauppauge, NY.
Male Formula. Performance Enhancer- 30 Capsules
100% Pharmaceutical Grade.
Yohimbe Bark Extract: 800 mg/ 3 Capsules
Smart Health USA, Beverly Hills, CA.
VHerbal Ultra- 30 tablets
Ultra Pleasure Delivery System. The All Natural Alternative.
Yohimbe Extract 2%: 250 mg/ 2 Tablets
Saint Rose Heights, Norwalk, CT.




Yohimbe Fuel- 50 capsules
Guaranteed Potency Yohimbe Bark Extract.
Standardized for Yohimbine.
Yohimbine: 8 mg/ capsule
Male Fuel- 60 capsules
Male Formula. With Yohimbe Bark Extract.
Standardized for Yohimbine.
Yohimbe Bark Extract: 800 mg/ 6 Capsules
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Powerman Yohimbe Power- 100 Capsules
The All Night Long Pill. Pure Yohimbe Bark Extract.
Yohimbe Bark Extract: 225 mg/ Capsule
Standardized for 4.5 mg yohimbine alkaloids
Powerman Yohimbe Stack- 30 Tablets
The All Night Long Pill. Pure Yohimbe Bark Extract.
Yohimbe Bark Extract: 225 mg/ Tablet
Standardized for 4.5 mg yohimbine alkaloids
Factorial and Fractional Factorial Design.
Statistical Design Software.
Minitab 12 for Windows. Release 12.21. Minitab Inc. 1998
Methods.
Experimental Design.
Run voltage, temperature, buffer composition, buffer pH, buffer ionic strength,
injection type, injection setpoint, organic modifier concentration, and effective column
length comprised the factors chosen for fractional factorial design one (Table 4).
A two-level, one-quarter fractional factorial experimental design at resolution four
was compiled using design generators provided by Minitab (Figure 6). Four centerpoints
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Table 4. Factor levels chosen for FFD1 . Low level represented by -, high level represented by +,
centerpoints represented by 0. Factors D and F based on factors C and E, respectively (i.e. when C is -,
corresponding to citrate buffer, D + is 6. When C is +, D + corresponds to phosphate buffer at pH 8).
Factor
>
A B C D(C-) D(C+) E F(E-) F(E+) G H J
















25 10 Citrate 3 3 Electro-
kinetic
5 20 25 0 0.01
+ 35 20 Phosphate 6 8 Pressure 15 50 75 10 0.1
0 30 15 X 4.5 6.5 X 10 35 50 1 0.05
G = ABCD H = ACEF J = CDEF
Figure 6. Design generators for factorial design one.
Generated by Minitab Statistical Software.
were added to complete the design, resulting in 68 experimental runs performed in
duplicate (Table 5).
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Table 5. DesignMatrix for the factorial design one. Design generators G=ABCD, H=ACEF, and J=CDEF.
The level of factor G for any run is determined by the levels of factors A, B, C, and D for that run.
(example: run three. A=-, B=+, C=-, D=-, E=-, F=- Therefore the level of factor
G = ABCD = (-)(+)(-)(-) = -, level of factor H = ACEF = (-)(-)(-)(-) = +)
Run# A B C D E F G H J
1 - - - - - - + + +
2 + - - - - - - - +
3 - + - - - - - + +
4 + + - - - - + - +
5 - - + - - - - - -
6 + - + - - - + + -
7 - + + - - - + - -
8 + + + - - - - + -
9 - - - + - - - + -
10 + - - + - - + - -
11 - + - + - - + + -
12 + + - + - - - - -
13 - - + + - - + - +
14 + - + + - - - + +
15 - + + + - - - - +
16 + + + + - - + + +
17 - - - - + - + - -
18 + - - - + - - + -
19 - + - - + - - - -
20 + + - - + - + + -
21 - - + - + - - + +
22 + - + - + - + - +
23 - + + - + - + + +
24 + + + - + - - - +
25 - - - + + - - - +
26 + - - + + - + + +
27 - + - + + - + - +
28 + + - + + - - + +
29 - - + + + - + + -
30 + - + + + - - - -
31 - + + + + - - + -
32 + + + + + - + - -
33 - - - - - + + - -
34 + - - - - + - + -
35 - + - - - + - - -
36 + + - - - + + + -
37 - - + - - + - + +
38 + - + - - + + - +
39 - + + - - + + + +
40 + + + - - + - - +
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41 - - - + - + - - +
42 + - - + - + + + +
43 - + - + - + + - +
44 + + - + - + - + +
45 - - + + - + + + -
46 + - + + - + - - -
47 - + + + - + - + -
48 + + + + - + + - -
49 - - - - + + + + +
50 + - - - + + - - +
51 - + - - + + - + +
52 + + - - + + + - +
53 - - + - + + - - -
54 + - + - + + + + -
55 - + + - + + + - -
56 + + + - + + - + -
57 - - - + + + - + -
58 + - - + + + + - -
59 - + - + + + + + -
60 + + - + + + - - -
61 - - + + + + + - +
62 + - + + + + - + +
63 - + + + + + - - +
64 + + + + + + + + +
65 0 0 0 0 0 0 0 0 0
66 0 0 0 0 0 0 0 0 0
67 0 0 0 0 0 0 0 0 0
68 0 0 0 0 0 0 0 0 0
The secondary investigation focused on three factors at two levels, buffer pH,
buffer ionic strength, and run voltage (Table 6).
A full factorial design of
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experimental runs and an additional two centerpoint
runs were completed, totaling ten runs in duplicate (Table 7).
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Table 6. Factor levels chosen for factorial design two. (Low level represented by
high level represented by +, centerpoints represented by 0)
Factor A B
Level PH Voltage Ionic Strength
4 10 0.01
+ 5 20 0.1
0 4.5 15 0.05
Table 7. Design matrix for factorial design two.
Run# Level A Level B Level C
1 - - -
2 + - -
3 - + -
4 + + -
5 - - +
6 + - +
7 - + +
8 + + +
9 0 0 0
10 0 0 0
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Preparation ofBuffers for Capillary Electrophoresis.
Citrate and Phosphate buffers employed in this investigation were prepared
utilizing the Henderson-Hasselbach (Equation 4) and ionic strength (Equation 5)
equations toward a known pH and ionic strength (Scheme 4).
pH = pKa + log [conjugate base]
[conjugate acid]
I = 0.5Z (cjZj2)
Buffers that did not measure to the calculated pH were recalculated with a
correction factor equal to that of the deviation (i.e. a buffer with a measured pH of 5.2 has
a deviation of 0.2 pH units. 0.2 is the correction factor. The buffer is recalculated
towards a pH of4.8.)
All buffer solutions were filtered through a 0.2 pm Acrodisc syringe
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Citrate buffer: pH = 5
.00,





















The Henderson-Hasselbach equation for these conditions is
5.00 = 4.76 + log (y/x)




Substituting Equation 6 for x
1.738 = y/(0. 10 -3y)
Solving for y yields
y
= 0.028 M = [HA=]
Substituting y into Equation 6
x
= 0.016 M = [H2A']
Scheme 4: Buffer calculations for citrate buffer pH 5.00, 1
= 0.10.
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Preparation of Standards for Capillary Electrophoresis.
Yohimbine and Eserine Standard (Factorial Design One).
A measured amount of yohimbine was quantitatively transferred to a 10 mL
volumetric flask. Buffer corresponding to the proper pH and ionic strength for the
experimental run was added to volume and mixed to yield a 2000 ppm standard.
A measured amount of eserine was quantitatively transferred to a 10 ml
volumetric flask. Buffer corresponding to the proper pH and ionic strength for the
experimental run was added to volume and mixed to yield a 2000 ppm standard.
Equal parts 2000 ppm yohimbine standard and 2000 ppm eserine standard were
added to a 10 ml conical plastic graduated centrifuge tube and vortexed to yield a
standard of 1000 ppm in both yohimbine and eserine. The standard solution was then
filtered through a 0.2 pm Acrodisc syringe filter disc.
Yohimbine and Eserine Standard (Factorial Design Two).
Deionized ultra filtrated water was employed to utilize the stacking effects that
occur when a buffer of lower ionic strength than the separation buffer is present in the
injection vial (50). A measured amount of yohimbine was quantitatively transferred to a
10 ml volumetric flask. Deionized water was added to volume and mixed to yield a 2000
ppm standard.
A measured amount of eserine was quantitatively transferred to a 10 ml
volumetric flask. Deionized water was added to volume and mixed to yield a 2000 ppm
standard.
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Equal parts 2000 ppm yohimbine standard and 2000 ppm eserine standard were
added to a 10 mL conical plastic graduated centrifuge tube and vortexed to yield a
standard of 1000 ppm in both yohimbine and eserine. The standard solution was then
filtered through a 0.2 pm Acrodisc syringe filter disc.
Methods ofExtraction.
Extraction ofYohimbine from Liquid Products.
Portions of 1 ml of ethanol based liquid products were evaporated with a
centrivap concentrator. The resulting solids were reconstituted with deionized water and
filtered with a 0.2 pm Acrodisc syringe filter. An aliquot of the filtrate was combined
with an aliquot of internal standard and buffer and injected onto the column.
Water based products were filtered with a 0.2 mm Acrodisc syringe filter, and an
aliquot of the filtrate was combined with an aliquot of internal standard and buffer and
injected onto the column.
Extraction ofYohimbine from Solid Products.
Capsules were broken open and the cellulose casing discarded. Portions of the
powders removed were utilized for this investigation. Tablets were crushed with amortar
and pestle, and the resultant powder utilized for this investigation.
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Extraction Method One.
Portions of 0.1 gram of bark powder (0.1 gram of product) was wet and brought
to volume in a 10 ml volumetric flask with deionized water. This slurry was agitated for
20 minutes at room temperature. The contents were then filtered through a 0.2pm
Acrodisc syringe filter, and an aliquot of the filtrate was injected onto the column with an
aliquot of an internal standard and buffer.
Extraction Method Two.
Portions of 0.05 gram of bark powder (0.5 gram of product) was wet and brought
to volume in a 10 ml volumetric flask with deionized water. This slurry was agitated for
20 minutes at room temperature. The contents were then filtered through a 0.2 mm
Acrodisc syringe filter, and an aliquot of the filtrate was injected onto the column with an
aliquot of an internal standard and buffer.
Extraction Method Three.
Portions of 0.1 gram of bark powder (0.1 gram of product) was wet and brought
to volume in a 100 ml volumetric flask with deionized water. This slurry was transferred
to a 1 L Erlenmeyer flask and agitated for 60 minutes at
60
C in a Labline
environmental orbital shaker. The contents were allowed to cool, and the liquid decanted
and filtered through a 0.2pm Acrodisc syringe filter. An aliquot of the filtrate was
injected onto the column with an aliquot of an internal standard and buffer.
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ExtractionMethod Four.
Portions of 0.1 gram of bark powder (0.1 gram of product) was wet and brought
to volume in a 100 ml volumetric flask with deionized water. This slurry was transferred
to a 250 ml Erlenmeyer flask and sonnicated for 15 minutes at room temperature. The
contents were allowed to cool to room temperature, and the liquid decanted and filtered
through a 0.2pm Acrodisc syringe filter. An aliquot of the filtrate was injected onto the
column with an aliquot of an internal standard and buffer.
Extraction Method Five.
Portions of 0.1 gram of bark powder (0.1 gram of product) was wet and brought
to volume in a 10 ml volumetric flask with 10 ml of 95% ethanol. This slurry was
agitated for 20 minutes at room temperature. The contents were then filtered through a
0.2 pm Acrodisc syringe filter. The ethanol was evaporated with a rotary evaporator
concentrator, and the remaining powder reconstituted into 3 ml of deionized water. The
solution was then filtered through a 0.2 pm Acrodisc syringe filter, and an aliquot of the
filtrate was injected onto the column with an aliquot of an internal standard and buffer.
Extraction Method Six.
Portions of 0.1 gram of bark powder (0.1 gram of product) was wet and brought
to volume in a 10 ml volumetric flask with chloroform and added to a 125 ml separatory
funnel. It was equilibrated with 10 ml of deionized water, and the organic layer
collected. The aqueous layer was washed with a portion of 10 ml chloroform. The
organic layers were combined, and filtered through a 0.2 pm Acrodisc syringe filter. The
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chloroform was removed with a rotary evaporator, and the resultant solids reconstituted
into 3 ml of deionized water. The solution was filtered through a 0.2 pm Acrodisc
syringe filter, and an aliquot was injected onto the column with an aliquot of an internal
standard and buffer.
Extraction Method Seven.
Solid phase extraction was performed on an Alltech reverse phase 900 mg Cis
solid phase extraction cartridge. The cartridge was first conditioned with 3 ml of
methanol, followed by 3 ml of deionized water. 1 ml of sample dissolved in deionized
water (0.05 g/ 10 ml) was applied. A 5 ml portion of water was pushed through the
column, and collected as a fraction. 3 ml fractions of 10% methanol in water, 50%
methanol in water, 75% methanol in water, and 100% methanol were collected
successively. The methanol was removed from these fractions with a centrivap
concentrator. The resultant solids were reconstituted with 1 ml deionized water, and an
aliquot was injected onto the column with an aliquot of an internal standard and buffer to
determine the target fraction.
Extraction Method Eight.
Solid phase extraction was performed on an Alltech reverse phase 300 mg Ci8
solid phase extraction cartridge. The cartridge was first conditioned with 3 ml of
methanol, followed by 3 ml of deionized water. 1 ml of sample dissolved in deionized
water (0.05 g/ 10 ml) was applied. A 3 ml portion of water was pushed through the
column, and collected as a fraction. 1 ml fractions of 10% methanol in water, 50%
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methanol in water, 75% methanol in water, and 100% methanol were collected
successively. The methanol was removed from these fractions with a centrivap
concentrator. The resultant solids were reconstituted with 1 ml deionized water, and an
aliquot was injected onto the column with an aliquot of an internal standard and buffer to
determine the target fraction.
ExtractionMethod Nine.
Solid phase extraction was performed on an Alltech reverse phase 900 mg Cig
solid phase extraction cartridge. The cartridge was first conditioned with 3 ml of
isopropanol, followed by 3 ml of deionized water. 1 ml of sample dissolved in deionized
water (0.05 g/ 10 ml) was applied. A 5 ml portion of water was pushed through the
column, and collected as a fraction. Two successive 3 ml fractions of 100% isopropanol
were collected, followed by two successive 3 ml fraction of 2% ammonium hydroxide in
isopropanol. The isopropanol was removed from 1 ml portions of these fractions with a
centrivap concentrator. The resultant solids were reconstituted with 1 ml deionized
water, and an aliquot was injected onto the column with an aliquot of an internal standard
and buffer to determine the target fraction.
Extraction Method Ten.
Solid phase extraction was performed on an Alltech reverse phase 300 mg Cig
solid phase extraction cartridge. The cartridge was first conditioned with 3 ml of
isopropanol, followed by 3 ml of deionized water. 1 ml of sample dissolved in deionized
water (0.05 g/ 10 ml) was applied. A 3 ml portion of water was pushed through the
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column, and collected as a fraction. Two successive 1 ml fractions of 100% isopropanol
were collected, followed by two successive 1 ml fraction of 2% ammonium hydroxide in
isopropanol. The isopropanol was removed from these fractions with a centrivap
concentrator. The resultant solids were reconstituted with 1 ml deionized water, and an
aliquot was injected onto the column with an aliquot of an internal standard and buffer to
determine the target fraction.
Optimized Extraction Conditions for Commercial Samples.
The protocol of extraction five was expanded for continued investigation. Sample
mass and ethanol volume were varied between high and low levels to determine the most
efficient extraction conditions. The final conditions for real sample analysis involved the
use of 0.05 g sample dissolved into 10 ml of 95% ethanol in a volumetric flask. The
ethanol was then decanted and filtered through a 0.2 mm Acrodisc syringe filter. 1 ml
aliquots of this slurry were evaporated with a Labconco rotary concentrator (60 C
* 45
min). The resultant solids were reconstituted into 1 ml ofwarm deionized water, filtered
through a 0.2 mm Acrodisc syringe filter, and an aliquot injected along with a volume of
eserine standard and buffer.
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Instrumental.
Conditioning of the Capillary Column.
New capillary columns were preconditioned utilizing a standard method. A 45
minute flush with 1.0 N sodium hydroxide, followed by a 45 minute flush with 0.1 N
sodium hydroxide assured a uniform surface on the interior of the capillary walls. This
was followed by flushes with CE grade water and then the requisite buffer for the
analysis at times of 30 and 45 minutes respectively. An additional 90 minutes of flush
time were needed for phosphate buffers to reach equilibrium with the column and reduce
background noise during experimental runs.
Column conditioning after each unique set of duplicate runs involved two
successive 20 minute buffer flushes. Upon completion of a sequence, columns were
flushed with CE grade water to remove buffer salts and maintain capillary composition
prior to storage.
Capillary Electrophoresis Methods.
Eighteen unique instrumental methods were employed for the primary factorial
design (Table 8). These methods were combined with changes in buffer characteristics
(ionic strength, pH, type) and capillary column length to give the necessary conditions in
Table 5. Electropherograms were collected at 230 and 280 nm (54).
Three methods were employed for the secondary factorial experimental design
(Table 9) in which voltage, buffer pH and buffer ionic strength were the variables.
Electropherograms were collected at 215, 220, and 230 nm following the
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Table 8. Methods employed for the factorial design one.
Methods 17 and 18 represent centerpoints.








1 yoh01 Electrokinetic 5kV 5 25 20
2 yoh02 Electrokinetic 15 kV 5 25 20
3 yoh03 Electrokinetic 5kV 5 35 10
4 yoh04 Electrokinetic 15 kV 5 35 10
5 yoh05 Pressure 20 mbar 5 25 20
6 yoh06 Pressure 50 mbar 5 25 20
7 yoh07 Pressure 20 mbar 5 35 10
8 yoh08 Pressure 50 mbar 5 35 10
9 yoh09 Electrokinetic 5kV 5 25 10
10 yoh10 Electrokinetic 15 kV 5 25 10
11 yoh11 Electrokinetic 5kV 5 35 20
12 yoh12 Electrokinetic 15 kV 5 35 20
13 yoh13 Pressure 20 mbar 5 25 10
14 yoh14 Pressure 50 mbar 5 25 10
15 yoh15 Pressure 20 mbar 5 35 20
16 yoh16 Pressure 50 mbar 5 35 20
17 yoh17 Electrokinetic 10 kV 5 30 15
18 yoh18 Pressure 35 mbar 5 30 15
analysis of 3D spectra from fractional factorial design one demonstrating maxima
for the yohimbine peak near 220 nm.
Table 9. Methods employed for factorial design two.
Method 3 represents a centerpoint.








1 Yoh10V Electrokinetic 10 5 30 10
2 Yoh20V Electrokinetic 10 5 30 20
3 Yoh4_5 Electrokinetic 10 5 30 15
Final investigation of commercial samples and yohimbe bark powder was
conducted utilizing a 25 cm effective length capillary column, total length 32.5 cm, with
a 20 kV run voltage (Table 10).
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10 25 Electrokinetic 5 5 35 20
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RESULTS.
Factorial Design One (Fractional).
A lA fractional factorial design investigating nine factors at two levels was
accomplished at resolution four. 68 experimental runs
(29"2
= 64, and 4 centerpoints
=
68) were completed in duplicate according to Table 5. The descriptive statistics of the
fractional factorial design are shown in Table 1 1 . A full table of the results
Table 11. Descriptive statistics of response ranges for
the factorial design one.
Response N Minimum Maximum Mean Median
MigTime(1) 68 0.7 51.2 13.6 8.1
MigTime(2) 68 0.7 59.9 15.7 9.5
Area(1) 68 1.5 150.4 29.6 15.9
Area(2) 68 5.0 344.4 74.2 42.4
Symmetry(1) 68 0.01 22.20 1.22 0.20
Symmetry(2) 68 0.00 9.53 0.48 0.19
Plates(1) 68 120 358699 68852 44556
Plates(2) 68 25 540072 75669 43699
Resolution 68 0.18 28.43 6.70 6.21
Selectivity 68 1.04 1.35 1.13 1.13
are included in the appendix. Using the statistical software Minitab, p values were
determined for responses including migration time and peak area of each compound, and
the resolution between the peaks characteristic for eserine (peak 1) and yohimbine (peak
2) (Table 12). A value ofp < 0.05 is considered to be statistically significant.
Temperature.
Temperature has no statistically significant effect in the range chosen for this
experimental design.
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Table 12. p values of responses from factorial design one. A value ofp < 0.05 is a
significant factor, p < 0.1 is relevant (i.e. Mig (1)
=Migration time for peak one, corresponding
to eserine. Mig (2)
= Migration time for peak two, corresponding to yohimbine.)
Factor Mig(1) Mig(2) Area(1) Area(2) Resolution
Temperature 0.963 0.659 0.926 0.725 0.079
Voltage 0.000 0.000 0.000 0.000 0.001
Buffer type 0.560 0.295 0.437 0.285 0.929
Buffer pH 0.000 0.000 0.066 0.047 0.000
Injection type 0.515 0.694 0.000 0.000 0.001
Injection setpoint 0.401 0.532 0.000 0.000 0.002
Column eff length 0.000 0.000 0.378 0.774 0.000
Methanol % 0.069 0.048 0.700 0.794 0.172
Ionic strength 0.000 0.000 0.169 0.332 0.000
Voltage.
As the voltage was increased, migration times were lower, the observed peak
areas decreased, and resolution increased (Figure 7).
Buffer Type.
Peak symmetry and selectivity are considerably lower when phosphate buffers are
employed as opposed to citrate buffers. There is no significant effect of buffer type on
migration time or peak area of either compound.
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Figure 7. Phosphate buffer pH
=
8.0, 1
= 0.10. Electrokinetic injection (5 kV * 5 sec) Column effective
length 75 cm. a) Run 13 Voltage





= 10.29; b) Run 16. Voltage
= 20 kV. Area(l)
= 14.8, Area(2)
= 18.4, R= 10.76.
Buffer pH.
Regardless of buffer composition, an increase in buffer pH corresponded to a
decrease in migration time and peak symmetry, and an increase in peak area. Resolution
decreased at a higher pH (Figure 8).
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Figure 8. Run voltage = 10 kV, Effective length
= 25 cm, Electrokinetic injection (5kV
* 5 sec).
a) Run 2. Citrate pH 3. Area(l)
=
20.3, area(2)




= 29.4. R = 2.01.
Injection Type.
The main effects plot of the peak area results for this design show that the areas of
both peak one and peak two were generally lower with the use of pressure injection
(Figure 9). Peak areas were higher with the use of electrokinetic injection. Resolution is
lower for electrokinetic injection.
Injection Setpoint.
Peak area and peak symmetry increased as a result of an increase in injection
level. Resolution decreased as the injection level increased (Figure 9).
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Figure 9. Main effects plot Area(2). This typical output from statistical software denotes the general trend
of experimental main effects on the are of peak 2. Trends are read from a lower level (-1) to a higher level
(1) of factors A-J in fractional factorial design one. A=temperature, B=voltage, C=buffer type, D=buffer
pH, E=injection type, F=injection setpoint,
G=










Migration times were higher for the higher-level effective column length of 75 cm
(Figure 10). Resolution was also increased by an increase in column length.
Methanol.
The addition of an organic modifier in the form of methanol slightly increased
migration times. This did not have a statistically significant effect on resolution between
the peaks corresponding to eserine and yohimbine.
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Figure 10. Phosphate buffer pH 8, 1 = 0.10. Electrokinetic injection (5 kV * 5 sec) a) run 15, 25 cm
effective length. R = 4.06. b) Run 16, 75 cm effective length. R = 10.76.
Ionic Strength.
An increase in the ionic strength of the buffer system caused a significant increase in
migration time, theoretical plates, selectivity, and resolution (Figure 1 1). The symmetry
ofpeak one decreased with the increase of ionic strength.
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Figure 1 1. Citrate pH = 3. Electrokinetic injection. Run voltage = 10 kV, Effective length = 75 cm. a) Run
2. 1 = 0.10. Injection = low. b) Run 34. 1 = 0.01. Injection = high.
Factorial Design Two (Full).
A full factorial experimental design investigating three factors at two levels
(23
=
8, + 2 centerpoints =10) was completed. The descriptive statistics of the fractional
factorial design are shown in Table 13. A full table of the results are included in the
appendix. Using the statistical software Minitab, p values were determined for responses
including migration time and peak area of each compound, and the resolution between
the peaks corresponding to eserine (peak 1) and yohimbine (peak 2) (Table 14).
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Table 13. Descriptive statistics of response ranges for
the factorial design two.
Response N Minimum Maximum Mean Median
MigTime(1) 10 1.6 6.5 3.5 3.19
MigTime(2) 10 1.8 7.9 4.01 3.62
Area(1) 10 8.2 34.0 16.0 15.1
Area(2) 10 67.7 243.7 122.8 114.5
Symmetry(1) 10 0.05 0.15 0.12 0.13
Symmetry(2) 10 0.03 0.12 0.07 0.06
Plates(1) 10 1146 34762 13079 9572
Plates(2) 10 3905 32197 13856 12530
Resolution 10 1.08 6.61 3.80 3.43
Selectivity 10 1.1 1.22 1.15 1.14
Table 14. p values of responses from factorial design two. A value ofp
< 0.05 is a
significant factor, p < 0.1 is relevant (i.e. Mig (1)
=Migration time for peak one, corresponding
to eserine. Mig (2)
=Migration time for peak two, corresponding to yohimbine.)
Factor Mig (1) Mig (2) Area(1) Area (2) Resolution
Buffer pH 0.260 0.239 0.234 0.012 0.417
Voltage 0.052 0.060 0.096 0.004 0.854
Ionic Strength 0.079 0.082 0.230 0.008 0.010
Voltage.
An increase in voltage corresponded to a decrease of migration time and a
decrease in the resultant peak area (Figure 12). There is no significant effect of voltage
on resolution in this experimental system (p
= 0.854). The effect on area (pi = 0.096) and
migration time (pi = 0.052, p2
=
0.060) are considered relevant, while a significant effect











Figure 12. Citrate pH = 4, 1
= 0.1. a) Run 5, voltage
= 10 kV. b) Run 7, voltage = 20 kV.
Buffer pH.
The increase of buffer pH decreased migration time and peak area (Figure 13).
There is no mathematically significant effect of pH on resolution in this experimental
system (p
= 0.417). The area of the peak corresponding to yohimbine was significantly
effected by a variation of pH in this range (p2
= 0.012). Peak area was demonstrated as
higher toward the lower pH.
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Figure 13. Buffer ionic strength I = 0.1, run voltage = 10 kV. a) pH 4. b) pH 5.
Ionic Strength.
An increase in ionic strength increased migration time, peak area, theoretical plate
count, and resolution (Figure 14). The area of the peak corresponding to yohimbine was
effected significantly by the variation of ionic strength in this range (p2 = 0.008). Ionic
strength had a relevant effect on the migration times of both peaks one and two (pi =
0.079, p2 = 0.082).
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Figure 14. Citrate buffer pH = 4, run voltage = 10 kV. a) Run 1.1
= 0.01. b) Run 5. 1 = 0.1.
Optimized Experimental Conditions.
The separation conditions were chosen as follows: A 25 cm effective length by
25 pm internal diameter fused silica capillary was employed at a temperature of
35
C.
The run voltage was set at 20 kV for 10 minutes to afford a resolved separation of
yohimbine alkaloids. The buffer chosen was citrate, pH 4.0, diluted 1:10 in sample vials.
An electrokinetic injection (5 kV
* 5 seconds) was utilized.
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Commercially Available Products.
Several products were purchased from local merchants. These products were
assigned sample identifications (ID) (Table 15).
Table 15. List of assigned product ID and product potency claim.
Sample ID Company Product Claim
C1 Natrol Yohimbe Bark: Whole Herb Powder 500 mg yohimbe bark/ capsule
C2 Action Labs Yohimbe Powermax 2000 1000 mg yohimbe bark extract complex/ capsule
C3 Power Force Male Formula 266.67 mg yohimbe bark extract/ capsule
C4 GNC Yohimbe 451 9 mg yohimbine alkaloid/capsule
C5 Twinlab Yohimbe Fuel 8 mg yohimbine/capsule
C6 Twinlab Powerman Yohimbe Power 4.5 mg yohimbine alkaloids/ capsule
C7 Twinlab Male Fuel 133.33 mg yohimbe bark extract/ capsule
T1 Irwin Naturals Yohimbe Plus 666.67 mg yohimbe bark powder/ tablet
T2 Only Natural Yohimbe 1000 Plus 500 mg yohimbe bark/ tablet
T3 Twinlab Powerman Yohimbe Stack 4.5 mg yohimbine alkaloids/ tablet
T4 Smart Health USA Herbal V Ultra 125 mg yohimbe extract 2%/ tablet
T5 Great American Nutrition Men's Performance 250 mg yohimbe bark/ tablet
L1 Action Labs Yohimbe Powermax 2000 1000 mg yohimbe bark extract/ ml
L2 Sobe Energy No potency claim on label.
YBP Yohimbe Bark Powder up to 6% yohimbine
The method above was employed to determine the amounts of yohimbine in
commercially available preparations. Several extraction methods were investigated and
compared towards the determination ofyohimbine in a number of samples (Table 1 6).
Extraction five was chosen for further investigation. The amount ofproduct and
the amount of solvent were varied from a low to a high level, and amid point
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Table 16. Comparison often extraction conditions. The values are reported
as a weight percentage ofyohimbine in product (Extractions 7-10 were completed
for C4 and ybp only.)
Sample ID Extract 1 Extract 2 Extract 3 Extract 4 Extract 5 Extract 6 Extract 7 .Extract 8 Extract 9 Extract 10
C1 0.00 0.00 0.00 0.00 0.00 0.00
* * * *
C2 0.11 0.11 0.11 0.17 0.16 0.06
* * * *
C3 0.47 0.24 0.37 0.34 0.46 0.01
* * * *
C4 0.57 0.60 0.78 1.16 1.60 0.05 0.00 0.00 0.04 0.09
YBP 0.09 0.14 0.16 0.38 0.48 0.02 0.00 0.00 0.03 0.06
was included. The final extraction conditions were chosen at 0.05 g of sample dissolved
into 10 ml of ethanol.
The calibration curve for the yohimbine capillary electrophoretic method
routinely produced R2
> 0.9989, while allowing quantitation of the yohimbine peak over












Figure 15. Yohimbine analysis Calibration curve. Samples with detectable yohimbine ranged from 7 ppm
yohimbine to 67 ppm yohimbine in the sample vial (Sample vials included buffer and eserine standard)
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ppm yohimbine were included. A constant amount of internal standard (eserine) was
added to each sample and standard vial, and the time corrected area ratio (Equation 7)
between the peaks was utilized for the analysis.
yohimbine/eserine ratio = (Area ofyohimbine peak/Migration time of yohimbine peak)
(Area of eserine peak/Migration time of eserine peak)
The complete set of samples was extracted under these optimal conditions, and
injected onto the column utilizing the determined method (Table 17).
Table 17. Yohimbine in commercially available samples. Values reported as a percent







C1 0.00 0.00 500 mg bark powder
C2 0.16 1.83 1 000 mg extract complex
C3 0.26 1.82 266.67 mg bark extract
C4 1.61 10.67 9 mg yohimbine (2% extract)
C5 1.14 6.28 8 mg yohimbine
C6 0.60 2.94 4.5 mg yohimbine alkaloids
C7 0.19 1.58 133.33 mg bark extract
T1 0.16 2.62 666.67 mg bark powder
T2 0.00 0.00 500 mg bark
T3 0.32 5.12 4.5 mg yohimbine alkaloids
T4 0.06 0.71 125 mg yohimbine extract
T5 0.00 0.00 250 bark
L1 0.04 0.40 1000 mg bark extract
L2 0.00 0.00 No claim
YBP 0.51
*





0.015 g of standard yohimbine was added to an aliquot of sample Cl prior to
extraction to determine percent recovery of the extraction method. The extraction was
completed, and experimentally determined to have a 99.8 % recovery.
Ten successive injections of sample C7 were completed to evaluate method
reproducibility. The peak corresponding to the internal standard (eserine) averaged a
standardized area (area/ migration time) of 16.4 mAU/min with a standard deviation of
0.11 mAU/min. The peak corresponding to yohimbine averaged a standardized area of
1.3 mAU/min with a standard deviation of 0.10 mAU/min. When these areas were
combined to form the yohimbine/eserine ratio that was employed for data analysis, the
average ratio was 0.079. The standard deviation of this number was 0.0009.
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DISCUSSION.
Factorial Design One (Fractional).
Nine factors were investigated at two levels in a 1/8 fractional
29
factorial design
employing four centerpoints. Evaluation of the data was assisted with Minitab Version
12 statistical computing software. A discussion of the relevance of each factor in the
range of this examination follows. To review, when p < 0.05, an effect was considered
statistically significant; when 0.05 < p < 0.1, the effect was considered relevant.
Temperature.
Temperature was varied between a lower limit of
25
Celsius and an upper limit
of
35
Celsius. Temperature does not have a mathematically relevant effect on the
experimental outcomes of this system save resolution (p
= 0.079). A change in system
temperature can effect the buffer viscosity and result in modification of the
electroosmotic flow. Resolution was experimentally determined to be greater at a higher
temperature, an effect that corresponds to a decrease in electroosmotic flow. As the
overpowering EOF is lowered, the unique electrophoretic mobilities of each species are
increasingly expressed; this effect is demonstrated by an increase in resolution. There
were significant two factor interactions involving temperature and buffer type (p
=
0.021), and temperature and buffer pH (p
=
0.027) on resolution. Each of these
demonstrated a decreased resolution at a high level of both interaction factors.
Temperature would have to remain low if the higher level of buffer type and buffer pH
were to be employed.
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Voltage.
Voltage was varied from 10 kV at the lower level, to an upper level of 20 kV.
The maximum voltage that the system can provide is 30 kV. Migration times (pi =
0.000, p2 = 0.000), peak areas (pi = 0.000, p2 = 0.000), and the theoretical plate counts (pi
= 0.001, p2 = 0.026) of both compounds, as well as peak resolution (p
=
0.001) are
significantly effected by the variation of voltage under the constraints of this
experimental design. As the voltage increased, migration times decreased. This is
consistent with the equation describing electrophoretic mobility. The observed peak
areas decreased as the voltage was increased. This phenomenon is due to the increase in
electroosmotic flow and electrophoretic mobility. As a compound increases in mobility,
it is encountered by the detector for a shorter duration. This results in a seemingly
decreased area for the compound under these conditions. It may be a good practice to
divide the peak area by migration time to give a time-standardized area. This calculation
may limit reproducibility error of peak area due to variation in migration time. As
voltage is increased, the theoretical plate count increases as a result of the shorter
migration time, since time is a variable in theoretical plate calculations. Resolution
increases as voltage is increased in this model system, consistent with the equation
describing resolution.
There are several two-factor interactions that involve the separation voltage effect
on resolution: buffer type (p
= 0.022), buffer pH (p
= 0.01 1), column effective length (p
=
0.028), and buffer ionic strength (p
= 0.009). A high voltage combined with either a high
level buffer type or a high level buffer pH resulted in a decreased resolution. This result
60
should be expected, as an increase in any of these three individual effects acts to increase
the magnitude of the separation buffer electroosmotic flow. A strong EOF can
overpower the individual component electrophoretic mobilities, decreasing resolution. A
high voltage combined with a high level column effective length or a high level buffer
ionic strength worked to increase resolution. In these cases, individual compound
mobility characteristics are greater, expressed in either the greater separation distance or
the lower conductance, leading to a longer separation time.
The effects of voltage on the resolution of this separation system are complex
given the wide range of other experimental variants. Voltage was chosen as a factor in
the secondary analysis for this reason.
Buffer Type.
The investigation of buffer composition focused between two commercially




= 0.033), theoretical plate count (pi
= 0.000, p2
= 0.000), and selectivity (p
=
0.002) are significantly effected by the variance ofbuffer
composition. Peak symmetry is
considerably lower when
phosphate buffers are employed as opposed to citrate buffers.
This may be due in part to the complexing
reactions that phosphate tends to undergo with
the capillary walls (50).
The charged walls of the capillary, generators of electroosmotic
flow, can be partially or fully masked by this
phosphate complex. The loss in peak
symmetry may be a function
of the loss of uniform capillary walls, resulting in
sample-
wall interactions. Selectivity was experimentally determined as lower for the phosphate
buffers in comparison with the citrate buffers. Generally, citrate is easier to work with
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under these experimental conditions. This buffer type has a shorter equilibration time
with the column, as well as a lower absorptivity in the wavelength region of interest (200




The pKa of yohimbine has been experimentally determined as 8.30 (54). The pH
of the buffer solution was chosen to range from a lower limit of three to a higher limit of
eight based on commercially available buffers. Migration time (pi = 0.000, p2 = 0.000),
peak area (pi = 0.066, p2 = 0.047), peak symmetry (pi
= 0.000, p2 = 0.044), resolution (p
= 0.000), and selectivity (p
=
0.000) were significantly effected by the variation of buffer
pH through this range. The area (p2 = 0.047) and theoretical plate count (p2 = 0.012) of
the peak corresponding to yohimbine were also effected. Buffer pH has the largest
amount of significant effects of all factors included in the first set of experiments.
Regardless of buffer composition, an increase in buffer pH corresponded to a
decrease in migration time. This is consistent with the trend of electroosmotic flow to
increase as pH rises above three when utilizing a fused silica column. At a low pH
(pH<3), electroosmotic flow is considered to be low or negligible. An increase in buffer
pH corresponded to a decrease in peak areas, correlated to the amount of time required
for the compounds to move past the detector. A decline in symmetry is noted at the
higher pH levels, which may also be associated with the buffer composition: it was
experimentally determined that high pH phosphate
buffers have a much lower symmetry
then low pH citrate buffers. It is worthwhile to note that runs utilizing high pH citrate
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buffer had a lower symmetry than those employing low pH citrate buffer, with the same
trend observed for phosphate buffers.
Resolution was decreased at a higher pH of buffer, independent of buffer
composition. The electroosmotic flow may overpower the electrophoretic mobilities of
the two compounds at the higher pH. At a low pH, where the EOF is not as strong, there
is a higher resolution, as the compounds are separated more on the basis of their own
characteristic mobilities. There were no additional significant two-factor interactions on
resolution involving buffer pH other than those previously discussed.
The effects of pH on the resolution and peak area of this separation system are
important considerations in the choice for further work. As pH is increased, resolution,
peak area, and migration times decrease. A combination of these results would yield a
fast, yet possibly incomplete separation (R < 1.5) with lower than maximum peak areas.
A separation at a low pH would give an increase resolution, peak area, and a slower
migration time. Buffer pH is chosen as a factor in the secondary analysis to find a point
between the extremes where each outcome would be optimized: a fast, complete
separation with maximum peak areas.
Injection Type.
For the purpose of factorial design one, electrokinetic injection was utilized as the
lower level and a pressure injection comprised the upper level of the injection type factor.
Each injection type was utilized for two of the four centerpoints. Peak areas (pi
= 0.000,
p2
= 0.000), theoretical plate counts (pi
= 0.000, p2
= 0.001), and resolution (p
=
0.001)
are effected by the choice of injection type. Also, the symmetry ofpeak one was effected
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(pi = 0.017). The main effects plot of the peak area results for this design show that the
areas of both peak one and peak two were generally lower with the use of pressure
injection (Figure 9). Peak areas were higher with the use of electrokinetic injection. This
fact demonstrates that the separating species have a high electrophoretic mobility. The
movement of these species onto the column is higher under an applied voltage than with
the application of a pressure injection. Symmetry is higher for electrokinetic injection.
Theoretical plate count is lower for the electrokinetic injection compared to the pressure
injection mode. This is consistent with the increased peak area encountered with the
electrokinetic injection. Resolution is lower for electrokinetic injection, again consistent
with increased peak area. Band broadening in a larger injection plug is consistent with
the data encountered in this case. The sample plug in a pressure injection tends to have
less dispersion, as all species will have the same velocity as they are mobilized onto the
column. A pressure injection is less useful for analytical analysis, as the amount of
sample entering the column becomes a function of sample viscosity. There were no
significant two-factor interactions on resolution involving injection type. Work needed to
be done to increase peak symmetry to increase plate count and reproducibility, leading
towards the further investigation of electrokinetic injection for this analysis.
Injection Setpoint.
Under the condition of an electrokinetic injection (E-, Table 4), the lower level
was chosen to be 5 kV
* 5 seconds. The upper level was set at 15 kV
* 5 seconds. When
a pressure injection was employed (E+, Table 4), the lower level was set at 20 mbar
* 5
seconds, and the upper level was set at 50 mbar
* 5 seconds. Peak areas (pi = 0.000, p2 =
64
0.000), theoretical plate counts (pi = 0.000, p2 = 0.013), and resolution (p
=
0.002) were
effected by the variation in injection level. Peak area increased as the injection amount
increased. The model does not allow for a determination if this observation was linear, or
simply a trend. Peak symmetry increased as a result of an increase in injection level.
Theoretical plate count decreased as the injection level increased. Resolution decreased
as the injection level increased. An increase in peak area is a result of more analyte
introduced on column, consistent with an increase in peak width, which leads to a
decrease in resolution. There were no significant two-factor interactions on resolution
involving injection setpoint. The setpoint was chosen at a midpoint (electrokinetic
injection, 10 kV
* 5 sec) for the second analysis under the assumption that the optimized
method would include an injection setpoint that offered the greatest peak area while
maintaining resolution and peak symmetry. The setpoint meeting these criteria should
enable this method to investigate dilute samples.
Column Effective Length.
Column effective length was varied from 25 cm at the low level to 75 cm at the
upper level. This variance had a significant effect on migration time (pi = 0.000, p2 =
0.000), theoretical plate count (pi
= 0.000, p2 = 0.000), and resolution (p
= 0.000).
Migration times were longer for the higher-level column length. Theoretical plate counts
were also higher for the longer columns, as this calculation is based in part on column
length. Resolution was positively influenced by the increase in column length.
Differences in analyte mobility are expressed as an increased resolution as a result of an
increase in species migration distance before detection. There was a significant
two-
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factor interaction on resolution involving column effective length and buffer ionic
strength. At a high level of each factor, resolution was increased. This result is
consistent with both the effect of a longer capillary column as well as the increase of
ionic strength. This is a significant factor due to the effect on the implied separation
current. This current is decreased at a higher ionic strength, as well as at a higher column
effective length, and the combination of the two factors yields a significant difference.
Assuming a resolved separation, the column effective length can be chosen at a lower
level to limit migration times. This should assure a short analysis time.
Methanol.
A significant effect on migration time was seen for the peak corresponding to
yohimbine (p2 = 0.046) The addition of an organic modifier in the form of methanol
tended to decrease migration times. Organic modifiers have been shown to somewhat
mask the charge on molecules, either decreasing species mobility, or reducing wall
interactions (50). In this case, the wall charges were most likely masked, lowering
sample-wall interactions, and decreasing sample migration time. However, the addition
of methanol showed no significant effect on either peak area (pi
= 0.700, p2 = 0.794),
peak symmetry (pi
= 0.284, p2
= 0.496), or resolution (p
= 0.172), and was not involved
in any significant two factor




Ionic strength was varied over an order of magnitude. Migration times (pi =




0.000) of both peaks were effected by this variation of ionic
strength. Also, the symmetry of peak one was effected (pi = 0.000). An increase in the
ionic strength of the buffer system caused a significant increase in migration time, as the
EOF is decreased at a higher concentration. Theoretical plate count increased as a result
of increased ionic strength. Increased ionic strength causes an increase in the electric
field strength, a factor used in the calculation of theoretical plate values. Resolution and
selectivity increased with the increased ionic strength, a result of increased migration
time. The symmetry ofpeak one decreased with the increase of ionic strength. This may
be due to an increase in band broadening that occurred during the higher migration times.
Although there was no significant effect on peak area, and a detrimental effect on peak
symmetry, a higher resolution was demonstrated for a higher ionic strength, prompting
the further development of this factor. There were no additional significant two-factor
interactions on resolution involving ionic strength other than those previously discussed.
Intent ofFactorial Design Two.
Conditions were investigated that would allow for maximum peak area and
minimum migration time while maintaining a useful resolution. Resolution was
determined to be useful above a value of 5, allowing complete separation of the internal
standard and sample peaks while assuring an overall robust method. These
considerations were satisfied (Rave
=
6.3) while the migration times of the two peaks of
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interest remained within 0.5 minutes, a duration short enough to assume identical
separation conditions across the time frame.
Three factors from the primary investigation stood out as important to these
results. Ionic strength, buffer pH, and separation voltage were chosen as the main factors
toward the secondary factorial evaluation. The optimum conditions of the six other
factors were chosen based on results from the primary investigation.
Temperature had very little impact on the primary investigation. This factor was
set at
30
Celsius for factorial design two, slightly above ambient temperature for the
room to assure reproducibility. This factor was further adjusted at a later point.
Several responses favored the use of citrate buffers, including theoretical plate
count. The preconditioning of columns was much slower when employing phosphate
buffers, possibly owing to phosphate buffer salt complexation with the capillary wall.
For this reason, citrate buffer was chosen for continued evaluation.
Pressure injection is not very reproducible with the current hardware, and
differences in sample viscosity may lead to incorrect measurements. Peak areas from
electrokinetic injections were significantly higher than pressure injections at both levels,
but there was a resolution loss at the higher level. Electrokinetic injection at a low level
(5 kV * 5 sec) proved to be the best injection conditions evaluated in the primary
investigation, but may not be feasible when analyzing a very dilute sample. For this
reason, the setpoint for injection was chosen at the
midpoint (lOkV * 5 sec) for the
second factorial design, which could be further improved upon at a later time in the
investigation.
68
The addition ofmethanol as an organic modifier was shown to have no effect on
resolution or peak area, and was excluded from further investigation. Methanol may be
reintroduced into the experimental conditions in an effort to decrease migration times of
the yohimbine peak, assuming resolution is sustained.
The column effective length was determined to be mathematically significant on
the outcome of several responses, namely migration time and resolution. There were no
significant two-level interactions for this factor, necessitating no further examination in
the secondary investigation. Column effective length was chosen to be utilized at the
lower level (25 cm) in an effort to limit migration time for the secondary factorial design.
Factorial Design Two (Full).
A
23
full factorial design was completed, investigating three factors (separation
voltage, buffer pH, and buffer ionic strength) at two levels with two centerpoints. A
discussion of the relevance of each factor in the scope of this exploration follows.
Voltage.
Voltage was varied from a lower level of 10 kV to an upper level of 20 kV. No
significant main effect or interaction involving voltage was demonstrated in this design
other than the effect of voltage on the area of the peak corresponding to yohimbine (p2
=
0.004). The factor was determined to be relevant to migration time (pi = 0.052, p2 =
0.060) and peak area of the peak corresponding to eserine (pi
= 0.096). The higher level
of separation voltage was consistent with a decrease in migration time and peak area, as
the buffer electroosmotic flow and the mobility of each individual compound would be
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increased. Resolution was not significantly effected mathematically by the variation of
separation voltage in this range (p
= 0.854). There were no significant two or three factor
interactions on resolution involving voltage for this design. The absence of a significant
effect of voltage on resolution allows the employment of a high voltage, enabling the
shortest possible analysis time. Voltages above this range can be investigated.
Buffer pH.
The pH of citrate buffer was varied from a low level of 4.0 to an upper level of
5.0. An increase in buffer pH significantly decreased the area of the peak corresponding
to yohimbine (p2 = 0.012). There was no significant effect on migration time (pi = 0.260,
p2
=
0.239) or resolution (p
= 0.417). There were no significant two or three factor
interactions on resolution involving buffer pH. Further investigation should be orientated
toward the lower pH range to maximize yohimbine peak area.
Ionic Strength.
The ionic strength of the citrate buffers employed were varied from a low level of
I = 0.01, to a high level of 0.1, covering an order of magnitude and the range of
commercially available citrate buffers. This factor had a significant effect on both
resolution (p
= 0.010), and the area of the peak corresponding to yohimbine (p2
=
0.008),
increasing both. Ionic strength was considered relevant for the lengthening effect on
migration times (pi = 0.079, p2
= 0.082). There were no significant two or three factor
interactions on resolution involving ionic strength in this design. An increase in ionic
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strength decreases the electroosmotic flow of the buffer as the conductivity of solution is
decreased at a high level.
Optimized Experimental Conditions.
Buffer was chosen at pH = 4 to maximize the observed peak area, thereby
maximizing method sensitivity to yohimbine. Buffer ionic strength was chosen at I
= 0.1
to maximize both resolution and peak area.
Initial sample runs were completed at a run voltage of20 kV on a 25 cm effective
length fused silica capillary. There were four co-migrating peaks witnessed at the time
corresponding to the peak for yohimbine. An attempt to better resolve these peaks
involved the increase of column effective length to the higher limit investigated, 75 cm,
followed by an increase in run voltage to 30 kV. The peaks, although better separated,
were still not completely resolved. The increase in effective length had a significant
effect on analysis time, jumping to 20+ minutes from just over 3 minutes. The increase
in analysis time outweighed the increase in resolution (Rave = 1 -25 for a 25 cm column at
20 kV: Rave = 1 .35 for a 75 cm column at 30 kV).
Several extraction conditions were investigated (Table 16), and the employed
method effectively reduced the concentration of the on-column sample, resulting in a
resolved separation. This resolution was maintained at an effective length of 25 cm and
run voltage of20 kV.
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Commercially Available Samples.
Samples were randomly chosen from national distributors and purchased from
local merchants as listed in the Materials and Methods section. Several extraction
conditions were tested on a subsample of four products as well as a portion of yohimbine
bark (Table 16). The most complete extraction was afforded through extraction method
five ( 99.8 % recovery after optimization).
Yohimbe is reported as containing up to as much as 6 % yohimbine alkaloids.
Although yohimbine is the main active compound, there have been few studies of the
expected percent composition of this in the total bark. A commercial product may
therefore claim to be providing several hundred milligrams of yohimbe bark, without a
traceable level of yohimbine present. This was displayed by several of the samples in
question (Table 15).
This method proved to be useful for a broad range of product concentrations.
Several products, including Cl, T2, T5 and L2 demonstrated no detectable yohimbine.
The most potent product was C4 (Yohimbe Fuel by Twinlab), displaying 1.61 %
yohimbine (percent by weight) against a claim for 2 % yohimbine per capsule.
Summary.
The use of a fractional factorial design toward this investigationwas beneficial for
a number of reasons. First, the number of experimental runs that had to be completed in
order to attain this bulk of information was far less than a full design would have
afforded. Second, a large variation in experimental parameters was evaluated, gaining
valuable trend information. This broad range may not have been covered had the one
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factor at a time approach been utilized. Through this factorial design, it was possible to
determine the experimental conditions that would lead to an optimized separation without
disregarding the effects at extreme setpoints. And finally, interaction effects were
calculated and interpreted in method optimization. These effects are not evaluated using
the traditional one factor at a time method.
FutureWork.
Work in addition to this study could focus on the use of a mass spectrometer (MS)
in order to characterize the peaks that co-migrated with the peak characteristic to
yohimbine. An online CE-MS with an electrospray injection would allow for a second
dimension to be added to this method. The eserine and yohimbine peaks, as well as the
unknown peaks would be characterized and identified simultaneously while maintaining
a minute quantity of generated waste.
A focus on biological fluids could be completed. This effort would require the
development of an extraction of yohimbine from the biological fluid of interest, and
employ the same CE methods utilized in this investigation. An extraction of this type
would prove useful for a number of relevant studies.
An investigation could focus on the clearance time of this compound from the
human body, including the percentage that is removed from the body unchanged. This
work may lead to an investigation of the
therapeutic amounts of yohimbine needed in the
human body. Results from a study of this magnitude could prove useful in the regulation
of the product by the Federal government.
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Plates (1) Plates (2) Resolution Selectivity
1 37.4 44.0 4.5 38.8 0.04 0.26 89518 1790 2.82 1.18
2 6.3 7.6 20.3 63.9 0.43 0.32 78063 36031 10.06 1.20
3 3.4 4.3 10.4 68.0 0.35 0.37 84571 54102 15.3 1.27
4 33.8 45.7 15.6 54.2 0.48 0.31 199267 118471 28.43 1.35
5 5.8 6.7 27.1 62.9 0.09 0.04 9334 9395 3.25 1.14
6 37.1 42.2 28.7 54.1 0.11 0.01 52673 42974 7.31 1.14
7 21.3 24.1 12.0 30.1 0.09 0.12 45669 53199 6.93 1.13
8 2.5 2.8 13.4 31.2 0.22 0.07 6441 8037 2.71 1.14
9 1.5 1.6 8.1 51.5 0.07 0.02 1783 161 0.28 1.06
10 11.5 12.2 23.7 58.8 0.01 0.02 1628 1651 0.57 1.06
11 7.3 7.7 11.3 24.4 0.02 0.00 1545 1760 0.45 1.05
12 0.7 0.7 3.8 25.7 0.18 0.05 1922 139 0.18 1.04
13 22.2 24.2 24.8 28.8 0.22 0.40 189953 285267 10.29 1.09
14 2.3 2.5 24.8 29.4 0.83 0.16 12733 9294 2.01 1.08
15 1.2 1.3 10.9 11.8 0.12 0.78 44260 24703 4.06 1.10
16 9.3 10.2 14.8 18.4 0.14 0.29 192668 349542 10.76 1.09
17 36.0 42.4 20.4 41.5 0.13 1.13 34030 3705 3.61 1.18
18 5.5 6.3 17.9 42.7 5.00 0.53 29523 92268 7.13 1.14
19 3.0 3.4 8.3 20.4 5.21 0.29 41379 91817 7.78 1.13
20 18.7 21.4 6.3 21.0 3.21 0.59 184280 245394 15.56 1.14
21 8.1 9.6 24.1 52.8 0.29 0.21 69341 44424 9.45 1.18
22 51.1 59.9 12.8 24.2 0.49 0.27 153044 110945 14.15 1.17
23 30.2 35.2 4.9 13.5 2.81 0.27 212205 182835 17.68 1.17
24 3.0 3.5 8.1 17.9 0.23 0.21 119842 68168 11.29 1.17
25 4.6 5.0 10.2 24.6 0.24 0.29 69766 70182 5.99 1.10
26 24.5 29.2 8.3 13.0 0.94 0.79 149374 72380 13.59 1.19
27 14.0 16.6 7.4 6.4 0.51 0.68 197095 87767 14.75 1.18
28 1.8 1.9 3.7 9.4 0.41 0.29 84845 96277 6.47 1.09
29 14.0 14.8 3.1 8.5 0.10 0.31 128866 343645 6.67 1.06
30 1.4 1.5 3.7 17.2 0.12 0.15 39219 80385 2.72 1.05
31 0.8 0.8 1.5 8.3 0.25 0.19 48342 87909 3.02 1.05
32 5.9 6.3 1.9 5.8 0.11 0.25 151956 371845 6.39 1.05
33 46.0 52.5 98.7 254.0 3.91 0.34 45323 120367 8.80 1.14
34 5.8 6.5 117.8 240.4 22.20 9.53 1471 6868 1.58 1.13
35 3.1 3.4 49.3 104.4 17.91 5.31 2775 13355 2.10 1.12
36 17.6 19.8 41.0 112.9 9.57 2.16 30344 126440 6.98 1.12
37 8.0 9.4 113.9 219.0 0.13 0.08 20531 13382 5.10 1.18
38 51.2 59.9 92.1 167.2 0.52 0.25 97078 74261 11.35 1.17
39 30.2 35.4 55.9 106.1 0.25 0.19 128489 96391 13.07 1.17
40 2.9 3.4 43.0 80.7 0.13 0.08 16882 16019 4.86 1.16
41 4.4 4.8 100.2 203.2 0.26 0.09 1177 9566 1.22 1.1
42 30.8 33.8 150.4 263.5 0.15 0.14 39597 45897 4.74 1.1
43 19.7 21.7 57.8 113.7 0.11 0.12 54173 68701 6.02 1.1
83
44 1.7 1.9 43.4 96.9 0.08 0.15 1005 6138 1.19 1.11
45 13.2 14.3 96.0 313.5 0.03 0.01 1699 7032 1.02 1.08
46 1.2 1.3 52.5 344.4 0.09 0.03 1682 270 0.34 1.06
47 0.7 0.8 27.5 152.9 0.10 0.04 1336 279 0.36 1.07
48 5.6 6.0 48.9 169.7 0.08 0.13 1576 8156 1.00 1.07
49 37.0 43.9 33.0 118.3 0.21 0.76 119.56 25.19 2.84 1.19
50 8.6 11.3 35.7 174.9 0.32 0.14 42503 14007 9.69 1.31
51 4.2 5.4 15.3 73.0 0.20 0.09 61349 19712 11.29 1.30
52 33.8 45.5 25.9 125.1 0.17 0.003 155309 71466 22.93 1.35
53 5.9 6.7 34.7 90.3 0.04 0.05 7037 6462 2.72 1.14
54 35.9 40.8 24.5 64.2 0.12 0.14 51546 44628 6.87 1.13
55 20.9 23.7 14.4 38.6 0.24 0.15 43655 47312 6.64 1.13
56 2.5 2.9 16.2 42.1 0.09 0.04 6820 12209 3.03 1.14
57 1.6 1.7 6.6 27.7 0.07 0.02 1541 304 0.33 1.06
58 12.4 13.1 12.4 23.7 0.02 0.04 1528 3614 0.72 1.06
59 7.4 7.8 5.6 12.2 0.11 0.02 2167 5300 0.80 1.06
60 0.7 0.7 3.0 13.4 0.14 0.00 1706 298 0.32 1.06
61 22.3 24.2 14.3 14.3 0.50 0.77 261346 341994 11.53 1.09
62 2.4 2.6 11.7 14.0 0.23 0.53 51961 32328 4.26 1.09
63 1.2 1.3 5.2 5.0 0.20 0.42 188263 104210 7.86 1.09
64 9.3 10.1 7.1 8.3 0.28 0.41 358699 540072 13.89 1.09
65 16.0 19.2 67.9 120.1 0.11 0.12 29908 24734 7.36 1.20
66 16.2 19.4 26.8 55.1 0.29 0.25 70069 40162 10.18 1.20
67 8.9 9.6 51.8 79.1 0.11 0.12 44851 45231 4.08 1.08
68 9.0 9.8 13.5 24.2 0.27 0.25 131267 131855 7.00 1.08















Plates (1) Plates (2) Resolution Selectivity
1 4.00 4.51 20.1 141.0 0.10 0.03 3375 3905 1.79 1.13
2 3.35 3.68 17.8 131.6 0.13 0.04 2577 4103 1.31 1.10
3 1.89 2.12 8.3 68.0 0.05 0.05 2614 4513 1.59 1.12
4 1.61 1.77 8.2 67.7 0.12 0.06 1146 4506 1.08 1.10
5 6.45 7.85 34.0 243.7 0.14 0.11 14643 14366 5.90 1.22
6 5.77 6.70 19.5 164.7 0.12 0.12 33222 30660 6.61 1.16
7 2.95 3.56 13.0 103.3 0.14 0.08 19311 19246 6.49 1.21
8 2.57 2.95 9.1 78.8 0.15 0.12 34762 32197 6.38 1.15
9 3.03 3.42 13.1 113.9 0.10 0.05 11032 14038 3.35 1.13
10 3.46 4.00 17.1 115.0 0.15 0.05 8112 11021 3.50 1.16
84





Interaction Plot (data means) for Resolution



























Figure 17. Two factor interactions on resolution: factorial design two (full)
Centerpoint
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!




k' Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
, | | | | | | |
2.622
- 48.98016 14.02603 0.55 0.0592 10876
End of Report
Instrument 1 11/15/99 1:06:58 PM
Jonathan Cooper Page 2 of 2














11/13/99 4:46:17 PM by Jonathan Cooper
(modified after loading)
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
instrument 1 11/14/99 8:00:47 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YA112010.D Sample Name: c2
MigTime
k'
Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | | I | | | |
2.629 - 46.91885 16.78396 0.33 0.0455 18536
3.161 - 4.23694 1.27554 0.95 0.0444 28019 6.95 1.20
End of Report ***
istrument 1 11/14/99 8:00:47 PM Jonathan Cooper Page 2 of 2














11/13/99 5:15:47 PM by Jonathan Cooper
(modified after loading)
C:\HPCHEM\l\METHODS\CEP\YOHIMBIN.M



































Signal 1: DADl C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
tistrument 1 11/14/99 8:01:31 PM Jonathan Cooper Page 1 of 2




Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I I | | | |
2.655 - 45.54269 16.28253 0.34 0.0455 18906
3.195
- 6.55139 2.82070 0.87 0.0344 47899 7.94 1.20
End of Report ***
strument 1 11/14/99 '8:01:31 PM Jonathan
Cooper Page 2 of 2










11/15/99 4:07:49 AM Seq. Line
c4 Vial
Jonathan Cooper inj
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11/14/99 10:20:27 PM by Jonathan Cooper
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
istrument 1 11/15/99 1:05:51 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112014.D Sample Name: c4
MigTime
k'
Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I I | | | |
2.571 - 47.85159 14.28505 0.61 0.0580 10871
3.073 - 39.13450 11.21555 0.74 0.0612 13975 4.94 1.20
End of Report
istrument 1 11/15/99 1:05:51 PM Jonathan Cooper Page 2 of 2










11/15/99 4:33:15 AM Seq. Line
c5 Vial
Jonathan Cooper Inj
C : \HPCHEM\1\METH0DS\CEP\Y0HIMBIN . M
11/14/99 10:20:27 PM by Jonathan Cooper
C:\HPCHEM\1\METH0DS\CEP\Y0HIMBIN.M





































Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
istrument 1 11/15/99 1:04:27 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112015.D Sample Name:
c5
MigTime
k" Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | | I | | | |
2.570 - 46.39185 13.94060 0.61 0.0573 11163
3.083 - 23.19514 8.03220 0.75 0.0491 21824 5.67 1.20
End of Report
:nstrument 1 11/15/99 1:04:27 PM Jonathan Cooper Page 2 of 2
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
instrument 1 11/15/99 1:03:29 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112016.D Sample Name: c6
MigTime
k'
Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I I | | | ,
2.580 - 48.27141 14.88949 0.53 0.0557 11889
3.103 - 28.60966 8.10988 0.84 0.0583 15672 5.39 1.20
End of Report ***
instrument 1 11/15/99 1:03:29 PM Jonathan Cooper Page 2 of 2
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
instrument 1 11/15/99 1:02:25 PM Jonathan Cooper Page 1 of 2




Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I I | | | |
2.576 - 42.36260 13.20951 0.63 0.0557 11855
3.105
- 4.02156 1.80595 0.85 0.0435 28260 6.27 1.21
End of Report ***
instrument 1 11/15/99 1:02:25 PM Jonathan Cooper Page 2 of 2
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11/14/99 10:20:27 PM by Jonathan Cooper
C:\HPCHEM\l\METHODS\CEP\YOHIMBIN.M



































Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 1:01:39 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112018.D Sample Name: tl
MigTime
k'
Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I , | , _ , ,
2.618 - 50.44037 15.12113 0.54 0.0565 11910
3.173 - 3.67186 1.73705 1.03 0.0378 39075 6.91 1.21
End of Report ***
Instrument 1 11/15/99 1:01:39 PM Jonathan Cooper Page 2 of 2
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 1:00:48 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112019.D Sample Name: t2
MigTime
k'
Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I I | , , ,
2.644 - 46.89314 14.44299 0.57 0.0557 12485
End of Report ***
Instrument 1 11/15/99 1:00:48 PM Jonathan Cooper page 2 of 2










































Signal 1: DAD1 C, Sig=212,16 Ref=450,80
























Instrument 1 11/15/99 12:55:42 PM Jonathan Cooper Page 1 of 2










11/15/99 7:05:51 AM Seq. Line
t4 Vial
Jonathan Cooper inj
C : \HPCHEM\ 1 \METHODS \CEP\YOHIMBIN . M
11/14/99 10:20:27 PM by Jonathan Cooper
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 12:56:31 PM Jonathan Cooper Page 1 of 2
)ata File C:\HPCHEM\1\DATA\Y111299\YC112021.D Sample Name: t4
MigTime k1 Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | , I | , , ,
2.619 - 43.96003 13.84906 0.55 0.0557 12257
3.160 - 1.53238 7.32475e-l 1.05 0.0417 31872 6.53 1.21
End of Report ***
tostrument 1 11/15/99 12:56:31 PM Jonathan Cooper Page 2 of 2
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 12:57:04 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112022.D Sample Name: t5
MigTime k' Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
, | I I | , , ,
2.646 - 48.72402 14.28163 0.52 0.0578 11620
End of Report ***
Instrument 1 11/15/99 12:57:04 PM Jonathan Cooper Page 2 of 2
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 12:57:48 PM Jonathan Cooper Page 1 of 2














11/14/99 10:20:27 PM by Jonathan Cooper
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Signal 1: DADl C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 12:58:52 PM Jonathan Cooper Page 1 of 2
Data File C:\HPCHEM\1\DATA\Y111299\YC112024.D Sample
Name: L2
MigTime
k* Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | | | | | | |
2.662 - 26.10143 9.27425 0.70 0.0507 15292
End of Report ***
Instrument 1 11/15/99 12:58:52 PM Jonathan Cooper Page 2 of 2
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Signal 1: DAD1 C, Sig=212,16 Ref=450,80
Results obtained with enhanced integrator!
Instrument 1 11/15/99 12:59:30 PM Jonathan Cooper Page 1 of 2
lata File C:\HPCHEM\1\DATA\Y111299\YC112025.D Sample Name: ybp
MigTime
k'
Area Height Symm. Width Plates Resol Select
[min] [mAU*s] [mAU] [min] ution ivity
I | I I | , , |
2.645 - 46.13070 14.28615 0.56 0.0549 12854
3.188 - 11.02444 4.10314 0.99 0.0480 24442 6.21 1.21
End of Report ***
Instrument 1 11/15/99 12:59:30 PM Jonathan Cooper Page 2 of 2
